1 study found for:    strive anti-jcv
Show Display Options
Rank Status Study
1 Unknown  Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patients
Condition: Relapsing-remitting Multiple Sclerosis
Intervention:

Indicates status has not been verified in more than two years